Clinical Trial Update: Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating how HIV infection and active tuberculosis affect immune responses to the trivalent influenza vaccine in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Snippet

Sponsor: University of Witwatersrand, South Africa | Conditions: Influenza, HIV | Phase 4 | Status: COMPLETED